Investors
Information Disclosure
-
NOTIFICATION OF BOARD MEETING2024.03.01
-
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE NEW INDICATION APPLICATION FOR MARKETING OF ANLOTINIB HYDROCHLORIDE CAPSULES AND ANTI PD-L1 "BENMELSTOBART (TQB2450 INJECTION)"2024.02.28
-
VOLUNTARY ANNOUNCEMENT - ANTI PD-L1 “BENMELSTOBART (TQB2450 INJECTION)” INCLUDED IN PRIORITY REVIEW AND APPROVAL PROCEDURES2024.02.07
-
DISCLOSEABLE TRANSACTION - DISPOSAL OF EQUITY INTEREST IN CP QINGDAO2024.02.06
-
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 20242024.02.01
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2024.01.26
-
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS - NEW ARRANGEMENTS ON DISSEMINATION OF CORPORATE COMMUNICATIONS2024.01.26
-
VOLUNTARY ANNOUNCEMENT - PROGRESS UPDATE ON THE "SHARE PURCHASE PLAN FOR AN AGGREGATE AMOUNT OF NOT EXCEEDING HK$1 BILLION"2024.01.24